Mark Kiel, MD;PhD

Ann Arbor, Michigan, United States
Dr. Mark Kiel is the founder and chief scientific officer at Genomenon, where he oversees the company’s scientific direction and product development. After spending 15 years preparing for a life of academic research, Mark became convinced that revolutionary change in genomics was more likely to emerge from industry.
In 2014, he founded Genomenon, an AI-driven genomics company addressing the challenge of connecting pharma researchers with evidence in the literature to help diagnose and treat patients with rare genetic diseases and cancer.
Speaking In
3:15 PM - 3:30 PM (PDT)
Monday, June 13
Genomenon’s AI-driven genomic engine leverages billions of genetic associations between diseases,…